Australia markets closed

Ultragenyx Pharmaceutical Inc. (RARE)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
42.75-0.45 (-1.04%)
At close: 04:00PM EDT
43.58 +0.83 (+1.94%)
After hours: 05:20PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
213,584
132,944
307,584
713,526
Other short-term investments
363,625
614,818
432,612
488,007
Total cash
577,209
747,762
740,196
1,201,533
Net receivables
73,390
40,445
28,432
23,093
Inventory
33,969
26,766
16,231
13,048
Other current assets
47,616
68,926
71,745
-
Total current assets
732,184
883,899
856,604
1,295,304
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
373,967
323,107
226,221
151,431
Accumulated depreciation
-83,401
-63,381
-50,038
-37,392
Net property, plant and equipment
290,566
259,726
176,183
114,039
Equity and other investments
199,901
148,970
293,858
165,881
Goodwill
44,406
44,406
44,406
44,406
Intangible assets
166,271
160,105
130,788
131,113
Other long-term assets
57,685
48,338
20,558
8,812
Total non-current assets
758,829
661,545
665,793
464,251
Total assets
1,491,013
1,545,444
1,522,397
1,759,555
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
42,114
43,274
17,138
12,923
Accrued liabilities
196,486
204,678
145,555
108,491
Deferred revenues
0
1,479
7,609
59,219
Other current liabilities
29,242
-
-
-
Total current liabilities
280,437
261,210
181,368
189,609
Non-current liabilities
Deferred tax liabilities
30,058
31,667
33,306
33,306
Deferred revenues
-
0
1,467
7,349
Other long-term liabilities
12,205
4,820
1,005
-
Total non-current liabilities
935,162
931,740
418,468
415,571
Total liabilities
1,215,599
1,192,950
599,836
605,180
Stockholders' equity
Common stock
82
70
69
67
Retained earnings
-3,387,661
-2,781,022
-2,073,601
-1,619,576
Accumulated other comprehensive income
647
-6,573
-1,404
689
Total stockholders' equity
275,414
352,494
922,561
1,154,375
Total liabilities and stockholders' equity
1,491,013
1,545,444
1,522,397
1,759,555